Member Info for Deal3r

I agree Miggy. I'm a holder. I doubt I could sell out..
The news so far has been positive and the unsubstantiated reports of people making fast recovery is good. Who knows if they were on the drug or not as but I gives a bit of confidence.

Richard and his team are on to something

Very interesting miggy.

...also the reason I first looked into SNG.

I had a couple of meetings with Woodford last year. He is a man who still today believes he is right and did nothing wrong. Arrogant and angry. I understand he is trying to buy some his unquoted biotech stocks and illiquid stuff back.

Ghia @ 19.27

So a fund manager will only generally invest in stocks that he knows and has researched.
Their fund can invest in pretty much anything but is governed by rules. UCITS rules generally prevent investing over 10% into a single stock.
But each fund is in an IA sector (UK smaller companies or UK Equity income sector) to meet those rules they have to invest 80% of the funds in stocks defined in that sector. Eg UK smallers are bottom 10% of quoted companies by mkt cap. A manger can invest 20% where he likes even overseas. That's how this stock ended up in Woodford s fund.

DubleD
This is where different worlds collide.
You have a guy working his blx off trying to launch a drug he has worked on for years. And then having to do corporate stuff like raise money to enable it's launch.

You have investors who research a company by the stock cos they like and believe in the short and support it. Others in the city some of whom Invest to support the story as well, but there are some who try make a turn. Everyone has a different but important role to play. Even the punters who buy stock and sell it a few days later having made or lost a few quid.

Richard needs to play his part. Some providing enough information at the right time cos investors hate the vacuum of uncertainty and no news.

DubleD

So if there is a small company (like this one) and the number of shares traded is quite low, a holder of large number of shares ( many thousand times size of the average trade volume each day) can not just sell their holding as there is no one who can buy in that size. The market makers take on stock and drop the price to generate a trade to get rid of the stock at a profit.

That is the definition of liquidity. The ability to trade in size without damaging the price. The seller may represent 30% of the volume for the day

There are a few fund managers who have picked these up for their funds and will be now holding not dumping the stock. Their motivation will be different from Lansdowne and Link.

This also underpins the downside.

The thought that if it doesn't get perfect results in the hospital trial due to patients being further along in the illness, the home trial, taken up early I hope will demonstrate a degree of effectivness. The min price I guess is 30-40p + via an oversold 20p.

We will always get some sellers into strength, particularly as link needs to dispose of them. I suspect some funds will start picking small holdings up.
I have a call with a couple tommorow and will get a feeling on their view, but known they won't be as well informed as many on this BB.

So FinnCap have put out a flash note which summarises the developments to date and reiterates 120p target and a further 240p on positive data in June. 80p of 120p relates to sng001 in covid use.

75 have been doses in hospital.

120 randomised patients at home with testing and courier of swabs and products.

Nothing new to many on the BB but this pushes info to wider fund management industry

On a 9bag on my lowest price paid.

Bought a few more more recently though. In for the long haul.

Good purchase of Mark Ronson's catalogue. Well respected and some great songs.I hope lockdown does not delay the signing of some big deals.The fundamentals look good for the long term as royalty rate increases, assets get revalued, assets are worked harder. But predicted on getting the iconic catalogues sighed up. Looking forward to seeing some big names soon.

So here is a late night thought....

I was having a think about the institutions and the different investment funds that have been buying SNG over the last month or so and wondered..

Is Woodford buying any?
Not that it matters, but he originally had massive conviction in the stock.
He is looking to buy back a number of unquoted and illiquid biotechs from Link.
He is ***** enough to believe he was not wrong last year and thinks he will be proved right.
He has the financial resources.

Just a thought.. night all.

Clearly not all investors who picked them up in the placing will be trading them. So we have an idea of which investment funds hold position and to what extent?

I will piece it together in a couple of days time when i get a few spare hours.

Not often.

First one was when Ian gowrie Smith bough into Black& Edginton a small marque company and turned it into Skyephama. B&E was very Small and I was 19 at the time. Most of my family are doctors so....
I usually buy a range of sizes but I bought SNG in early Jan on the COPD trial. I know model won't be much more effective than a coin toss.

I have tried to model upside and thought about the downsides as well.
At Xmas the stock was at 6p. But.... Consider the perseption of any stock held by Woodford last year. I known for a fact that they were sold off and in many cases shorted to hell. It was thought that the portfolio of micro caps was going to sold, so fire sale prices were set. If you look at FinnCap s valuation, its way higher than 10p for COPD and the other licence.

Has anyone, other than FinnCap modeled out upside downsides. I bought in in Jan as a potential treatment for COpd. However using a cost of at least £150 per dose, how does that back out to share price?

Iamrich.

Agreed. In Hull they tested SNG001 for the COPD trail, so I think they were well past 30 patients enrollment in this trial.

Not sure about supply but... There are a range on interferon beta drugs available on the NHS. They are not the same as SNG001 as they are injectable versions for MS. The cost is c£635 doe 4 injections.

A doctor I spoke to recently said their small hospital could not take part in the trial cos they could not obtain it.